nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—ABCB1—Rifampicin—leprosy	0.182	0.478	CbGbCtD
Telaprevir—CYP3A4—Rifampicin—leprosy	0.109	0.286	CbGbCtD
Telaprevir—CELA1—skin epidermis—leprosy	0.107	0.269	CbGeAlD
Telaprevir—CYP3A4—Dapsone—leprosy	0.0899	0.236	CbGbCtD
Telaprevir—CTSK—hindlimb—leprosy	0.0504	0.126	CbGeAlD
Telaprevir—CTSK—appendage—leprosy	0.0432	0.108	CbGeAlD
Telaprevir—CMA1—blood vessel—leprosy	0.0374	0.0936	CbGeAlD
Telaprevir—CELA1—skin of body—leprosy	0.0332	0.0832	CbGeAlD
Telaprevir—Acquired immunodeficiency syndrome—Thalidomide—leprosy	0.0284	0.129	CcSEcCtD
Telaprevir—Swelling face—Dapsone—leprosy	0.0234	0.106	CcSEcCtD
Telaprevir—CELA1—nervous system—leprosy	0.0205	0.0515	CbGeAlD
Telaprevir—CMA1—skin of body—leprosy	0.0173	0.0433	CbGeAlD
Telaprevir—Autoimmune disorder—Thalidomide—leprosy	0.0171	0.0775	CcSEcCtD
Telaprevir—CTSK—eye—leprosy	0.0128	0.0321	CbGeAlD
Telaprevir—CTSK—skin of body—leprosy	0.0111	0.0279	CbGeAlD
Telaprevir—Lymphopenia—Thalidomide—leprosy	0.0111	0.0506	CcSEcCtD
Telaprevir—CTSS—skin of body—leprosy	0.00976	0.0245	CbGeAlD
Telaprevir—Oral candidiasis—Thalidomide—leprosy	0.00897	0.0407	CcSEcCtD
Telaprevir—Hypothyroidism—Thalidomide—leprosy	0.00887	0.0403	CcSEcCtD
Telaprevir—CTSK—tendon—leprosy	0.00848	0.0212	CbGeAlD
Telaprevir—CTSS—tendon—leprosy	0.00743	0.0186	CbGeAlD
Telaprevir—CTSK—testis—leprosy	0.00702	0.0176	CbGeAlD
Telaprevir—CTSK—nervous system—leprosy	0.00689	0.0173	CbGeAlD
Telaprevir—Endocrine disorder—Thalidomide—leprosy	0.00687	0.0312	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Thalidomide—leprosy	0.00626	0.0285	CcSEcCtD
Telaprevir—CTSS—testis—leprosy	0.00615	0.0154	CbGeAlD
Telaprevir—Hyperuricaemia—Thalidomide—leprosy	0.00614	0.0279	CcSEcCtD
Telaprevir—CTSS—nervous system—leprosy	0.00604	0.0151	CbGeAlD
Telaprevir—Blood uric acid increased—Thalidomide—leprosy	0.0058	0.0264	CcSEcCtD
Telaprevir—Candida infection—Thalidomide—leprosy	0.00544	0.0247	CcSEcCtD
Telaprevir—Eczema—Thalidomide—leprosy	0.0046	0.0209	CcSEcCtD
Telaprevir—Renal failure acute—Thalidomide—leprosy	0.00448	0.0204	CcSEcCtD
Telaprevir—Blood creatinine increased—Thalidomide—leprosy	0.00387	0.0176	CcSEcCtD
Telaprevir—Hypokalaemia—Thalidomide—leprosy	0.00376	0.0171	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00372	0.0169	CcSEcCtD
Telaprevir—ABCB1—blood vessel—leprosy	0.00372	0.00932	CbGeAlD
Telaprevir—ORM1—nervous system—leprosy	0.00361	0.00903	CbGeAlD
Telaprevir—Eosinophilia—Thalidomide—leprosy	0.00354	0.0161	CcSEcCtD
Telaprevir—ALB—testis—leprosy	0.00322	0.00807	CbGeAlD
Telaprevir—Infestation NOS—Thalidomide—leprosy	0.00319	0.0145	CcSEcCtD
Telaprevir—Infestation—Thalidomide—leprosy	0.00319	0.0145	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00316	0.0144	CcSEcCtD
Telaprevir—Urinary tract disorder—Thalidomide—leprosy	0.00282	0.0128	CcSEcCtD
Telaprevir—Oedema peripheral—Thalidomide—leprosy	0.00282	0.0128	CcSEcCtD
Telaprevir—Urethral disorder—Thalidomide—leprosy	0.0028	0.0127	CcSEcCtD
Telaprevir—Erythema multiforme—Thalidomide—leprosy	0.0027	0.0123	CcSEcCtD
Telaprevir—Eye disorder—Thalidomide—leprosy	0.00267	0.0121	CcSEcCtD
Telaprevir—Vomiting—Dapsone—leprosy	0.00252	0.0115	CcSEcCtD
Telaprevir—Malnutrition—Thalidomide—leprosy	0.00249	0.0113	CcSEcCtD
Telaprevir—Dysgeusia—Thalidomide—leprosy	0.00244	0.0111	CcSEcCtD
Telaprevir—Nausea—Dapsone—leprosy	0.00236	0.0107	CcSEcCtD
Telaprevir—Anaemia—Thalidomide—leprosy	0.0023	0.0105	CcSEcCtD
Telaprevir—Syncope—Thalidomide—leprosy	0.00223	0.0101	CcSEcCtD
Telaprevir—Loss of consciousness—Thalidomide—leprosy	0.00219	0.00995	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00211	0.00957	CcSEcCtD
Telaprevir—Infection—Thalidomide—leprosy	0.00202	0.00917	CcSEcCtD
Telaprevir—Shock—Thalidomide—leprosy	0.002	0.00909	CcSEcCtD
Telaprevir—Nervous system disorder—Thalidomide—leprosy	0.00199	0.00906	CcSEcCtD
Telaprevir—Thrombocytopenia—Thalidomide—leprosy	0.00199	0.00904	CcSEcCtD
Telaprevir—Skin disorder—Thalidomide—leprosy	0.00197	0.00897	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Thalidomide—leprosy	0.00175	0.00797	CcSEcCtD
Telaprevir—Fatigue—Thalidomide—leprosy	0.00175	0.00796	CcSEcCtD
Telaprevir—Urticaria—Thalidomide—leprosy	0.00161	0.00734	CcSEcCtD
Telaprevir—CYP3A4—nervous system—leprosy	0.00151	0.00377	CbGeAlD
Telaprevir—Asthenia—Thalidomide—leprosy	0.00146	0.00663	CcSEcCtD
Telaprevir—Pruritus—Thalidomide—leprosy	0.00144	0.00653	CcSEcCtD
Telaprevir—Diarrhoea—Thalidomide—leprosy	0.00139	0.00632	CcSEcCtD
Telaprevir—Dizziness—Thalidomide—leprosy	0.00134	0.00611	CcSEcCtD
Telaprevir—Vomiting—Thalidomide—leprosy	0.00129	0.00587	CcSEcCtD
Telaprevir—Rash—Thalidomide—leprosy	0.00128	0.00582	CcSEcCtD
Telaprevir—Dermatitis—Thalidomide—leprosy	0.00128	0.00582	CcSEcCtD
Telaprevir—Nausea—Thalidomide—leprosy	0.00121	0.00549	CcSEcCtD
Telaprevir—ABCB1—testis—leprosy	0.00109	0.00272	CbGeAlD
Telaprevir—ABCB1—nervous system—leprosy	0.00107	0.00267	CbGeAlD
